Marilyn talks with the crew of the CDC's Act Against AIDS campaign about why she’s #DoingIt, and the importance of HIV testing in the transgender community. 

We're sharing this video to help promote the first-ever National Transgender HIV Testing Day - which is Monday, April 18, 2016. 

If you're in Philadelphia, stop by our Read more...

Every February, the prevention team at Mazzoni Center observes National Black HIV/AIDS Awareness Day with educational programming, outreach activities and HIV testing at events and in neighborhoods throughout Philadelphia. February 7 has passed but, for people living with HIV, every day brings awareness to the virus and the stigma that still exist.
 
Another day we celebrated in February is Valentine’s Day. For those who are single it can be a day to dread. This holiday can even be harder for those living with HIV, as love, romance and relationships may Read more...
Mazzoni Center LGBT health Philadelphia

Since 2013, The Real Impact Project (TRIP) has been charged with “being the change.” TRIP is an HIV/STI testing program of Mazzoni Center, as well as a social movement designed to raise awareness regarding sexual health among LGBTQ people of color.

Through creativity, advocacy, and empowerment, TRIP has made strides towards furthering the progress of LGBT culture for people of color within Philadelphia. With various events such as Soulful Picnic, Red Matters, and Rebel, TRIP has combined many of the dynamic elements that can be Read more...

Mazzoni Center LGBT HIV AIDS Philadelphia

I’ll be honest: I have very ambivalent feelings about “awareness days.” 

February 7 is National Black HIV/AIDS Awareness Day.  As an African American who has been working in the HIV prevention field for more than a decade, I’m well aware of this occasion and its significance.

On the one hand, I can absolutely appreciate the importance of marking a specific day each year to recognize the disproportionate impact that HIV is having on African-Americans in the United States, and Read more...

PrEP Truvada Pre Exposure Prophylaxis

It’s been three years since the FDA approved PrEP (Pre-Exposure Prophylaxis) for use by HIV-negative individuals to prevent them from being infected with HIV.  When PrEP as treatment was first introduced, there was a great deal of excitement in the provider community, particularly among those of us who specialize in treating people with HIV and those at higher risk of contracting it.  In its original clinical trials PrEP showed remarkable efficacy as a prevention tool.

Earlier this fall researchers at Kaiser Permanente Medical Center in San Francisco released what I Read more...

  •